Clario is a leading endpoint data solutions company that generates high quality clinical evidence for pharmaceutical, biotech, and medical device companies. We offer comprehensive evidence generating solutions - medical imaging, eCOA, cardiac safety, clinical events adjudication, respiratory, and precision motion. Since our founding more than 50 years ago, Clario has delivered deep scientific expertise and broad endpoint technologies to positively contribute to drug development. Thus far, our endpoint data solutions have supported over 27,000 clinical trials (including over 6000 each in medical imaging and eCOA, and over 13,000 each in cardiac safety and respiratory) in more than 100 countries and over 800 regulatory drug approvals, including over 60% of all FDA drug approvals since 2019.